ClinicalTrials.Veeva

Menu

Neuroimaging Mechanisms by Which Memory and Glucocorticoids Promote Risky Drinking

Yale University logo

Yale University

Status and phase

Completed
Early Phase 1

Conditions

Long-term Memory
Episodic Memory
Drinking Behavior
Alcohol Drinking

Treatments

Other: Placebo
Drug: Hydrocortisone 20 MG

Study type

Interventional

Funder types

Other

Identifiers

NCT04896489
2000026404

Details and patient eligibility

About

The purpose of this study is to determine whether hydrocortisone biases formation of alcohol-related memories to potentiate drinking.

Full description

This study aims to 1) Characterize the effect of elevated glucocorticoids during encoding on long-term memory for alcohol-related information; 2) Identify the neural mechanisms by which glucocorticoids influence encoding of alcohol-related experiences; and 3) Determine how glucocorticoid modulation of alcohol-related encoding relates to drinking after retrieving alcohol-related memories.

Enrollment

27 patients

Sex

All

Ages

21 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Able to read and write English
  • BMI 18-35
  • Beer drinking

Exclusion criteria

  • Meet current criteria for any substance use disorder, excluding caffeine
  • Current significant medical conditions or psychiatric symptoms requiring medication
  • Current use of medications/drugs that interfere with the HPA axis response
  • Peri and post-menopausal women, pregnant or lactating women, and those with hysterectomies
  • Metal in body (for MRI safety)
  • Systemic fungal infections (contraindication for hydrocortisone)
  • Known hypersensitivity to components of hydrocortisone tablets (hydrocortisone, calcium stearate, corn starch, lactose, mineral oil, sorbic acid, sucrose)

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

27 participants in 2 patient groups, including a placebo group

hydrocortisone
Experimental group
Description:
Participants receive hydrocortisone (20mg)
Treatment:
Drug: Hydrocortisone 20 MG
placebo
Placebo Comparator group
Description:
Participants receive placebo.
Treatment:
Other: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems